One of the key takeaways from the meeting, and from phase I of CHL UK, was that we tested and learned together for a whole year, but it’s now time to put our energy into what works.
A preclinical study just published in Nature shows that the company's investigational vaccine has shown positive early data for eliciting an immune response against SARS-CoV-2, the virus that causes COVID-19.
She also had help from Aflac. Ethan spent 40 months being treated for lymphoblastic lymphoma at the Aflac Cancer and Blood Disorders Center of Children’s Healthcare of Atlanta.
Since the start of the pandemic, Johnson & Johnson has been working to help address the devastating impacts of COVID-19 through the power of its science, the size of its global reach—and the know-how that comes from such experiences as standing up to challenges like HIV.
In the midst of the pandemic, society is evolving and adapting at an exponential pace. As recruitment and talent development specialists, we feel uniquely placed to provide insight into the direction that our core markets are taking as we work our way through this changed environment.
In late January—weeks before many people had even heard of the novel coronavirus—Ramon Polo, PharmD, Ph.D., started to work on finding solutions to fight the virus, which data suggested had the potential to become a global pandemic.
Stand Up To Cancer today announced a new $5 million grant from Bristol Myers Squibb to fund research and education efforts aimed at achieving health equity for underserved lung cancer patients, including Black people and people...
Lisa Ling talks with Dr. Francis Collins, Director, NIH about the latest on treatments and vaccines. Also, Harvard's Dr. Ashish Jha shares how the virus affects the body and Johns Hopkins' Dr. Tom Inglesby explains what the new data on spread means
The Biopharma Sustainability Roundtable (BSRT) has partnered with CECP’s CEO Investor Forum to enhance sustainability efforts and focus on long-term value creation. The two groups will co-host the first sector-specific CEO-Investor Forum in June 2021
One of the world's deadliest viral diseases was discovered in 1976 in Zaire, now known as the Democratic Republic of the Congo (DRC), near the Ebola River.
As the International Aids Society Conference kicks off virtually this year, we sat down with three attendees, including activist and actress Laverne Cox, to talk about their groundbreaking work with HIV/AIDS in the midst of a global pandemic.
We know distributed infrastructureThe changing energy landscape and rising pressures to integrate sustainable technologies are prodding businesses to...
Purpose 360 Podcast is a masterclass in unlocking the potential of social purpose to ignite business and social impact. Hosted by Carol Cone, CEO of...
The SCS Kingfisher certification mark is showing up on an increasing number of products around the world. It differentiates companies that are making...
The business landscape is reorienting itself and you can almost hear priorities shifting toward change-readiness and the bigger picture. And in this...
